Skip to main content
Top
Published in: Hepatology International 1/2013

01-03-2013 | Original Article

Analysis of discordance between transient elastography and liver biopsy for assessing liver fibrosis in chronic hepatitis B virus infection

Authors: Manoj Kumar, Archana Rastogi, Tarandeep Singh, Chhagan Bihari, Ekta Gupta, Praveen Sharma, Hitendra Garg, Ramesh Kumar, Vikram Bhatia, Pankaj Tyagi, Shiv K. Sarin

Published in: Hepatology International | Issue 1/2013

Login to get access

Abstract

Background

Transient elastography (TE) is used to assess liver fibrosis in chronic hepatitis B virus (CHBV) infection. However, factors affecting liver stiffness (LS) values and discordance between TE and liver biopsy in CHBV infection remain to be evaluated.

Aim

The aim is to define the optimal cutoff values of LS for significant fibrosis (≥F2) and cirrhosis (F4) and to study the clinical and histological variables associated with LS values and discordance between TE and liver biopsy in assessing liver fibrosis in CHBV-infected subjects.

Methods

Patients with CHBV infection (n = 200; 159 male; age 37.6 ± 3.7 years) underwent liver biopsy concomitantly with TE. Liver biopsy was scored for activity (Ishak score), fibrosis (METAVIR score), steatosis, cholestasis, and congestion. Hepatic fibrosis percentage was estimated by morphometry.

Results

Liver stiffness values were significantly correlated with histological activity index (HAI) score, F score, and fibrosis percentage. Optimal cutoff values for prediction of significant fibrosis and cirrhosis were 7.05 kPa [sensitivity 81.2 %; specificity 74 %; area under the receiver operating characteristic curve (AUROC) 0.850] and 10.85 kPa (sensitivity 87 %; specificity 85.3 %; AUROC 0.907), respectively. A total of 47 (23.5 %) [overestimation of actual fibrosis by TE, 34 (17 %); underestimation, 13 (6.5 %)] and 28 (14 %) [overestimation, 25 (12.5 %); underestimation, 3 (1.5 %)] patients showed discrepant results for diagnosis of significant fibrosis and cirrhosis, respectively. HAI and interquartile range (IQR) were the factors predictive of overestimation in cirrhosis.

Conclusions

Fibrosis and necroinflammatory activity are the main determinants of TE in CHBV infection. Overestimation of actual fibrosis stage by TE is common and is influenced by necroinflammatory activity and IQR for estimation of cirrhosis.
Literature
1.
go back to reference Talwalkar JA, Kurtz DM, Schoenleber SJ, et al. Ultrasound-based transient elastography for the detection of hepatic fibrosis: systemic review and meta-analysis. Clin Gastroenterol Hepatol 2007;5:1214–1220PubMedCrossRef Talwalkar JA, Kurtz DM, Schoenleber SJ, et al. Ultrasound-based transient elastography for the detection of hepatic fibrosis: systemic review and meta-analysis. Clin Gastroenterol Hepatol 2007;5:1214–1220PubMedCrossRef
2.
go back to reference Arena U, Vizzutti F, Corti G, et al. Acute viral hepatitis increases liver stiffness values measured by transient elastography. Hepatology 2008;47:380–384PubMedCrossRef Arena U, Vizzutti F, Corti G, et al. Acute viral hepatitis increases liver stiffness values measured by transient elastography. Hepatology 2008;47:380–384PubMedCrossRef
3.
go back to reference Millonig G, Reimann FM, Friedrich S, et al. Extrahepatic cholestasis increases liver stiffness (FibroScan) irrespective of fibrosis. Hepatology 2008;48:1718–1723PubMedCrossRef Millonig G, Reimann FM, Friedrich S, et al. Extrahepatic cholestasis increases liver stiffness (FibroScan) irrespective of fibrosis. Hepatology 2008;48:1718–1723PubMedCrossRef
4.
go back to reference Millonig G, Friedrich S, Adolf S, et al. Liver stiffness is directly influenced by central venous pressure. J Hepatol 2010;52:206–210PubMedCrossRef Millonig G, Friedrich S, Adolf S, et al. Liver stiffness is directly influenced by central venous pressure. J Hepatol 2010;52:206–210PubMedCrossRef
5.
go back to reference Chan HL, Wong GL, Choi PC, et al. Alanine aminotransferase-based algorithms of liver stiffness measurement by transient elastography (Fibroscan) for liver fibrosis in chronic hepatitis B. J Viral Hepat 2009;16(1):36–44PubMedCrossRef Chan HL, Wong GL, Choi PC, et al. Alanine aminotransferase-based algorithms of liver stiffness measurement by transient elastography (Fibroscan) for liver fibrosis in chronic hepatitis B. J Viral Hepat 2009;16(1):36–44PubMedCrossRef
6.
go back to reference Lucidarme D, Foucher J, Le Bail B, et al. Factors of accuracy of transient elastography (fibroscan) for the diagnosis of liver fibrosis in chronic hepatitis C. Hepatology 2009;49:1083–1089PubMedCrossRef Lucidarme D, Foucher J, Le Bail B, et al. Factors of accuracy of transient elastography (fibroscan) for the diagnosis of liver fibrosis in chronic hepatitis C. Hepatology 2009;49:1083–1089PubMedCrossRef
7.
go back to reference Kim SU, Seo YS, Cheong JY, et al. Factors that affect the diagnostic accuracy of liver fibrosis measurement by Fibroscan in patients with chronic hepatitis B. Aliment Pharmacol Ther 2010;32(3):498–505PubMedCrossRef Kim SU, Seo YS, Cheong JY, et al. Factors that affect the diagnostic accuracy of liver fibrosis measurement by Fibroscan in patients with chronic hepatitis B. Aliment Pharmacol Ther 2010;32(3):498–505PubMedCrossRef
8.
go back to reference Marcellin P, Ziol M, Bedossa P, et al. Non-invasive assessment of liver fibrosis by stiffness measurement in patients with chronic hepatitis B. Liver Int 2009;29(2):242–247PubMedCrossRef Marcellin P, Ziol M, Bedossa P, et al. Non-invasive assessment of liver fibrosis by stiffness measurement in patients with chronic hepatitis B. Liver Int 2009;29(2):242–247PubMedCrossRef
9.
go back to reference Kim do Y, Kim SU, Ahn SH, et al. Usefulness of FibroScan for detection of early compensated liver cirrhosis in chronic hepatitis B. Dig Dis Sci 2009;54(8):1758–1763PubMedCrossRef Kim do Y, Kim SU, Ahn SH, et al. Usefulness of FibroScan for detection of early compensated liver cirrhosis in chronic hepatitis B. Dig Dis Sci 2009;54(8):1758–1763PubMedCrossRef
10.
go back to reference Friedrich-Rust M, Ong MF, Martens S, et al. Performance of transient elastography for the staging of liver fibrosis: a meta-analysis. Gastroenterology 2008;134:960–974PubMedCrossRef Friedrich-Rust M, Ong MF, Martens S, et al. Performance of transient elastography for the staging of liver fibrosis: a meta-analysis. Gastroenterology 2008;134:960–974PubMedCrossRef
11.
go back to reference Fraquelli M, Rigamonti C, Casazza G, et al. Etiology-related determinants of liver stiffness values in chronic viral hepatitis B or C. J Hepatol 2011;54(4):621–628PubMedCrossRef Fraquelli M, Rigamonti C, Casazza G, et al. Etiology-related determinants of liver stiffness values in chronic viral hepatitis B or C. J Hepatol 2011;54(4):621–628PubMedCrossRef
13.
go back to reference Mehta SH, Lau B, Afdhal NH, et al. Exceeding the limits of liver histology markers. J Hepatol 2009;50:36–41PubMedCrossRef Mehta SH, Lau B, Afdhal NH, et al. Exceeding the limits of liver histology markers. J Hepatol 2009;50:36–41PubMedCrossRef
14.
go back to reference French METAVIR Cooperative Study Group. Intraobserver and interobserver variations in liver biopsies in patients with chronic hepatitis C. Hepatology 1994;20:15–20CrossRef French METAVIR Cooperative Study Group. Intraobserver and interobserver variations in liver biopsies in patients with chronic hepatitis C. Hepatology 1994;20:15–20CrossRef
15.
go back to reference Ishak K, Baptista A, Bianchi L, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995;22:696–699PubMedCrossRef Ishak K, Baptista A, Bianchi L, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995;22:696–699PubMedCrossRef
16.
go back to reference Brunt EM, Janney CG, Di Bisceglie AM, et al. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 1999;94:2467–2474PubMedCrossRef Brunt EM, Janney CG, Di Bisceglie AM, et al. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 1999;94:2467–2474PubMedCrossRef
17.
go back to reference Ziol M, Kettaneh A, Ganne-Carrié N, et al. Relationships between fibrosis amounts assessed by morphometry and liver stiffness measurements in chronic hepatitis or steatohepatitis. Eur J Gastroenterol Hepatol 2009;21(11):1261–1268PubMedCrossRef Ziol M, Kettaneh A, Ganne-Carrié N, et al. Relationships between fibrosis amounts assessed by morphometry and liver stiffness measurements in chronic hepatitis or steatohepatitis. Eur J Gastroenterol Hepatol 2009;21(11):1261–1268PubMedCrossRef
18.
go back to reference Goodman ZD, Becker RL, Pockros PJ, et al. Progression of fibrosis in chronic hepatitis C: evaluation by morphometric image analysis. Hepatology 2007;45:886–894PubMedCrossRef Goodman ZD, Becker RL, Pockros PJ, et al. Progression of fibrosis in chronic hepatitis C: evaluation by morphometric image analysis. Hepatology 2007;45:886–894PubMedCrossRef
19.
go back to reference Foucher J, Chanteloup E, Vergniol J, et al. Diagnosis of cirrhosis by transient elastography (Fibroscan): a prospective study. Gut 2006;55:403–408PubMedCrossRef Foucher J, Chanteloup E, Vergniol J, et al. Diagnosis of cirrhosis by transient elastography (Fibroscan): a prospective study. Gut 2006;55:403–408PubMedCrossRef
20.
go back to reference Coco B, Oliveri F, Maina AM, et al. Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases. J Viral Hepat 2007;14:360–369PubMedCrossRef Coco B, Oliveri F, Maina AM, et al. Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases. J Viral Hepat 2007;14:360–369PubMedCrossRef
21.
go back to reference Rigato I, Ostrow JD, Tiribelli C. Biochemical investigations in the management of liver disease. In Rodés J, Benhamou JP, Blei AT, et al., editors. Textbook of Hepatology: From Basic Science to Clinical Practice. 3rd ed. London: Blackwell Publishing Ltd; 2007. 451–478 Rigato I, Ostrow JD, Tiribelli C. Biochemical investigations in the management of liver disease. In Rodés J, Benhamou JP, Blei AT, et al., editors. Textbook of Hepatology: From Basic Science to Clinical Practice. 3rd ed. London: Blackwell Publishing Ltd; 2007. 451–478
22.
go back to reference Frulio N, Balabaud C, Bioulac-Sage P. Can elastometry be used for a better identification of cirrhosis? Clin Res Hepatol Gastroenterol 2011;35(3):166–168PubMedCrossRef Frulio N, Balabaud C, Bioulac-Sage P. Can elastometry be used for a better identification of cirrhosis? Clin Res Hepatol Gastroenterol 2011;35(3):166–168PubMedCrossRef
23.
go back to reference Nemesánszky E, Lott JA. Gamma-glutamyltransferase and its isoenzymes. Progress and problems. Clin Chem 1985;31:797–803PubMed Nemesánszky E, Lott JA. Gamma-glutamyltransferase and its isoenzymes. Progress and problems. Clin Chem 1985;31:797–803PubMed
24.
go back to reference Kumar M, Sarin SK, Hissar S, et al. Virological and histological features of chronic hepatitis B virus infected asymptomatic patients with persistently normal ALT. Gastroenterology 2008;134(5):1376–1384PubMedCrossRef Kumar M, Sarin SK, Hissar S, et al. Virological and histological features of chronic hepatitis B virus infected asymptomatic patients with persistently normal ALT. Gastroenterology 2008;134(5):1376–1384PubMedCrossRef
25.
go back to reference Poynard T, Halfon P, Castera L, et al. Standardization of ROC curve areas for diagnostic evaluation of liver fibrosis markers based on prevalences of fibrosis stages. Clin Chem 2007;53(9):1615–1622PubMedCrossRef Poynard T, Halfon P, Castera L, et al. Standardization of ROC curve areas for diagnostic evaluation of liver fibrosis markers based on prevalences of fibrosis stages. Clin Chem 2007;53(9):1615–1622PubMedCrossRef
26.
Metadata
Title
Analysis of discordance between transient elastography and liver biopsy for assessing liver fibrosis in chronic hepatitis B virus infection
Authors
Manoj Kumar
Archana Rastogi
Tarandeep Singh
Chhagan Bihari
Ekta Gupta
Praveen Sharma
Hitendra Garg
Ramesh Kumar
Vikram Bhatia
Pankaj Tyagi
Shiv K. Sarin
Publication date
01-03-2013
Publisher
Springer-Verlag
Published in
Hepatology International / Issue 1/2013
Print ISSN: 1936-0533
Electronic ISSN: 1936-0541
DOI
https://doi.org/10.1007/s12072-012-9380-5

Other articles of this Issue 1/2013

Hepatology International 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.